Delphinus Medical Technologies Secures $8M Venture Capital Financing
Summary
The funds will be used to start the commercialization process of SoftVue, a tomographic ultrasound imaging and risk assessment device that examines women’s breasts for the presence of benign and/or malignant masses.This screening tool was created at the Karmanos Cancer Institute and has undergone rigorous research and development over the past 10 years.The round of funding was co-led by Arboretum Ventures of Ann Arbor, Michigan, Beringea, LLC, through its InvestMichigan!The company began the process of securing venture capital in fall 2009 in order to design and build the first 10 machines that will be used in clinical settings around the globe.The company began the process of securing venture capital in fall 2009 in order to design and build the first 10 machines that will be used in clinical settings around the globe.
Funding
Review available funding amount, funding date, investors, and linked company information related to Delphinus Medical Technologies Secures $8M Venture Capital Financing in the interactive ISVWorld profile.